Table 1. Clinical characteristics and neurophysiological findings in patients with temporal lobe epilepsy.

Patient	Sex	Age, yrs	Epilepsy onset, yrs	MRI	Epileptogenic zone	Surgery	Histopathology	Seizure outcome	Followup, months
1	M	31	6	RTMes	RTMeslat	ETL	None	1a	18
2	M	36	9	RTMes	RTMesLat	ETL	None	2a	26
3	M	19	6	LTMes	LTMesLat	ETL	MES	1a	1
4	M	34	4	LTMes	LTMesLat	ETL	MES	1a	2
5	F	39	28	LTMes	LTMesLat	ETL	MES	1a	6
6	M	42	10	LTMes	LTMes	AMTL	MES	1a	18
7	F	39	12	RTMes	RTMes	AMTL	MES	1a	26
8	F	34	8	RTMesLat	RTMesLat	ETL	Ischemic lesion	1a	21
9	M	8	6	RTMes	RTMes	Lesionectomy plus	DNET	1a	12
10	M	7	1	RTLat	RTMesLat	Lesionectomy plus ETL	FCD	2a	14
11	F	38	19	RTMesBas	RTMesLat	ETL	FCD	1a	24
12	F	34	Birth	RTMes	RTMes	Lesionectomy + AMTL	Ganglioglioma (I WHO)	1a	24
13	M	16	11	LTLat	LTLat	Lesionectomy plus	Ganglioglioma (III WHO)	1a	3
14	M	29	13	RTMes	RTMes	Lesionectomy plus	Cranial trauma	1a	3
15	F	37	22	LTMes	LTMes	Amygdalohyppocamectomy	MES	1a	2
16	M	66	Absent	LT-insular lesion	None	Lesionectomy plus	Glioblastoma (IV WHO)	-	-
17	F	27	Absent	LTMes	None	Lesionectomy plus	Oligodendroglioma (II WHO)	-	-

Patients 1-7, afflicted with TLE; patients 8-14, afflicted with LTLE; patient 15, afflicted with focal hippocampal epilepsy with seizure-free TL; patients 16 and 17, afflicted with nonepileptic tumor. Tumor grading was according to the World Health Organization (WHO) histological classification. Seizure outcome: 1a (Engel class), completely seizure-free since surgery; 2a (Engel class), initially free of disabling seizures and only rare seizures at present. R, right; L, left; T, temporal; Lat, lateral; Bas, basolateral; MES, hippocampal mesial selerosis; ETL, extensive temporal lobectomy; AMTL, anteromesial temporal lobectomy; DNET, dysembryoplastic neuroepithelial tumors; FCD, focal cortical dysplasia; M, male; F, female.